Postoperative Complications in Patients With Obesity Hypoventilation Syndrome
OHBE
1 other identifier
observational
999
1 country
1
Brief Summary
Obstructive sleep apnea (OSA) and Obesity-Hypoventilation Syndrome (OHS) are common conditions in obesity, which may influence the prognosis in patients undergoing surgery. There is a need for simple screening tools to identify such patients at high risk. The current multicenter observational study aims to investigate occurrence of OSA and OHS in obese individuals undergoing elective abdominal surgery and further address its impact on perioperative and postoperative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 30, 2016
CompletedFirst Posted
Study publicly available on registry
December 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedApril 6, 2017
April 1, 2017
1.1 years
November 30, 2016
April 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative complications
72 hours
Study Arms (3)
Obstructive Sleep Apnea (OSA)
Patients with OSA
Obesity-Hypoventilation Syndrome (OHS)
Patients with OHS
Normal Blood Gases
Normal Blood Gases
Eligibility Criteria
All consecutive obese patients undergoing elective abdominal surgery
You may qualify if:
- Patients undergoing elective abdominal surgery
- Body-Mass-Index \>=30 kg/m2
- Ability to read and speak
- Signed informed consent.
You may not qualify if:
- Use of diuretics
- Use of theophylline
- Use of respiratory depressing drugs
- Severe lung disease (FEV1/FVC\<%50)
- Severe hearth failure (EF\<%35)
- Central nervous system or muscle disease
- Untreated hypothyroidism
- Renal failure (GFR\<50)
- Total parenteral nutrition more than 72 hours
- Hypokalemia
- Hyponatremia
- Hypomagnesemia
- Hypoalbuminemia
- Known sleep apnea or obesity hypoventilation syndrome
- Blood transfusion from blood bank within 72 hours prior to surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Marmara Universitylead
- Elazig Education and Research Hospitalcollaborator
- Mustafa Kemal Universitycollaborator
- Aydin Adnan Menderes Universitycollaborator
- TC Erciyes Universitycollaborator
- Sisli Hamidiye Etfal Training and Research Hospitalcollaborator
- Haydarpasa Numune Training and Research Hospitalcollaborator
- Fatih Sultan Mehmet Training and Research Hospitalcollaborator
- Konya Meram State Hospitalcollaborator
- Ankara City Hospital Bilkentcollaborator
- Adana Numune Training and Research Hospitalcollaborator
- Tepecik Training and Research Hospitalcollaborator
- Sakarya Universitycollaborator
- Ankara Universitycollaborator
- Kahramanmaras Sutcu Imam Universitycollaborator
- Trakya Universitycollaborator
- Karadeniz Technical Universitycollaborator
- Dr. Lutfi Kirdar Kartal Training and Research Hospitalcollaborator
- Turkiye Yuksek Ihtisas Education and Research Hospitalcollaborator
- Ufuk Universitycollaborator
- Kasımpasa Training and Research Hospitalcollaborator
- Nevsehir Public Hospitalcollaborator
- Hitit Universitycollaborator
- Bulent Ecevit Universitycollaborator
- Medipol Universitycollaborator
Study Sites (1)
Marmara University Pendik Training and Research Hospital
Istanbul, Turkey (Türkiye)
Biospecimen
Biochemistry, blood gases
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ismail Cinel, Prof Dr
Marmara University Medical School
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2016
First Posted
December 2, 2016
Study Start
November 1, 2016
Primary Completion
December 1, 2017
Study Completion
June 1, 2018
Last Updated
April 6, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share